Eagle Meds Services
Lytgobi (Futibatinib)
Available to SourceHuman Prescription DrugOncology & Specialty

Lytgobi (Futibatinib)

4 mg/1 · Tablet
By TAIHO PHARMACEUTICAL CO., LTD.

Futibatinib · Tablet · 4 mg

NDC
64842-0120
Route
Oral
Therapeutic class
Breast Cancer Resistance Protein Inhibitors [MoA], Fibroblast Growth Factor Receptor Inhibitors [MoA], Kinase Inhibitor , P-Glycoprotein Inhibitors [MoA]
Marketing category
NDA

Package sizes

  • 1 BLISTER PACK in 1 CARTON (64842-0120-4) / 21 TABLET in 1 BLISTER PACKNDC 64842-0120-4Available to Order
  • 1 BLISTER PACK in 1 CARTON (64842-0120-5) / 28 TABLET in 1 BLISTER PACKNDC 64842-0120-5Available to Order
  • 1 BLISTER PACK in 1 CARTON (64842-0120-6) / 35 TABLET in 1 BLISTER PACKNDC 64842-0120-6Available to Order
Request This Medication

*Expect a reply within 2 business hours with availability and pricing.

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request a quote

Request this medication.

Pick the package size you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.

  • DSCSA-compliant pedigree on every order
  • Cold-chain capable where applicable
  • Same-day fulfillment available for urgent needs
Requesting
Lytgobi (Futibatinib)
NDC 64842-0120